Line of work
SARS-CoV-2 Outcomes in Immunocompromised and Cancer Populations
This research analyzes the susceptibility, severity, and vaccination response of patients with cancer and other immune-mediated conditions during the COVID-19 pandemic. It utilizes large-scale cohort data to refine severity metrics and identify high-risk subgroups.
Anchor result
COVID-19 vaccination showed a 58% overall effectiveness in cancer patients, though effectiveness was notably lower in those receiving chemotherapy.
Related publications
2026
2025
2025
2024
2024
2024
2024
2023
2023
2023
2023
2022
2022
2022
2022
2022
2022
2022
2021
2021
2020